Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-152092
Filing Date
2012-04-05
Accepted
2012-04-05 16:34:09
Documents
8
Period of Report
2012-05-25
Effectiveness Date
2012-04-05

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE NOTICE & PROXY d285899ddef14a.htm DEF 14A 320278
2 GRAPHIC g285899g95l79.jpg GRAPHIC 7061
3 GRAPHIC g285899img1.jpg GRAPHIC 33587
4 GRAPHIC g285899img2.jpg GRAPHIC 45399
5 GRAPHIC g285899img3.jpg GRAPHIC 3988
6 GRAPHIC g285899img4.jpg GRAPHIC 15374
7 GRAPHIC g285899img5.jpg GRAPHIC 34640
8 GRAPHIC g285899img6.jpg GRAPHIC 10425
  Complete submission text file 0001193125-12-152092.txt   529852
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 12746071
SIC: 2835 In Vitro & In Vivo Diagnostic Substances